Compass pathways sued for purported theft of psilocybin trade secrets
This action arises out of Compass’s misappropriation of highly confidential and sensitive, proprietary information that Terran and the University of Maryland, Baltimore (“UMB”) spent years and substantial resources to develop.
Thompson kept his research confidential until he started filing patent applications “disclosing and claiming certain of his then-trade secret inventions”, in August 2019. As Terran claims, “He never disclosed it outside the scope of a confidentiality/non-disclosure agreement (NDA).” COMPASS reached out to Thompson in May 2019 and the two parties entered a mutual NDA, after which Thompson engaged in “numerous substantive discussions and negotiations” with the biotech company regarding a potential partnership. COMPASS “repeatedly emphasized” its excitement over that possibility, which would have led Thompson to disclose Psilocybin Trade Secrets in confidence. After that, “COMPASS misappropriated the Psilocybin Trade Secrets for itself,” secretly filing its own patent application…
Original Article (United States District Court for the District of Maryland & The Dales Report):
Jury Trial Demanded & Compass pathways sued for purported theft of psilocybin trade secrets &
Artwork Fair Use: Jatlas2